← Evidence map

ArticleThe New England journal of medicine2022

Teclistamab in Relapsed or Refractory Multiple Myeloma.

Edward R Scheffer Cliff et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36322860